drugset / Trial / NCT02105272

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

NCT02105272

Phase 3 Completed 237 enrolled Otsuka Pharmaceutical Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of OPC-1085EL ophthalmic solution in comparison with latanoprost ophthalmic solution in subjects who are insufficiently responsive to latanoprost ophthalmic solution.

Timeline

Start
2014-04
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule Other
Subject OPC-1085EL Unknown Other